← Leaderboards
Shelley S Tworoger
Brigham And Women'S Hospital
$12,562,498
Attributed
$13,233,041
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,233,041 · 10
By mechanism
P01$7,367,945 · 4
R01$5,368,115 · 4
R25$299,784 · 1
R03$197,197 · 1
Top collaborators
- Guillermo N Armaiz-Pena2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Olivia Ifeoma Okereke$11,031,577
Others in their field
Top investigators on “Health Study”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$530,153,267
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$512,334,270
- Lawrence Corey · Fred Hutchinson Cancer Center$507,254,127
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$417,776,536
Research focus
Health StudyNurses&AposWomanCancer RiskTumorPlasmaSamplingRisk FactorsFollow-UpTumor TissueCancer EtiologyMalignant Neoplasm Of OvaryBiologicalLeadEvaluationPreventionBloodResourcesBlood SpecimenSpecimenQuestionnairesEtiologyMalignant NeoplasmsLife Style
Grant awards (35)
The role of biobehavioral factors and anti-inflammatory medications on the ovarian tumor immune response$650,127
R01 · FY2025 · CA · contact PI
Integrative Molecular Epidemiology Workshop$299,784
R25 · FY2025 · CA · contact PI
The role of biobehavioral factors and anti-inflammatory medications on the ovarian tumor immune response$690,959
R01 · FY2023 · CA · contact PI
Project 3: Ovarian Cancer$310,029
P01 · FY2019 · CA · contact PI
Core A: Biospecimen and High-Dimensional Data Management Core$629,241
P01 · FY2018 · CA · contact PI
Project 3: Ovarian Cancer$326,903
P01 · FY2018 · CA · contact PI
Core A: Biospecimen and High-Dimensional Data Management Core$629,241
P01 · FY2017 · CA · contact PI
Project 3: Ovarian Cancer$326,903
P01 · FY2017 · CA · contact PI
Core A: Biospecimen and High-Dimensional Data Management Core$629,635
P01 · FY2016 · CA · contact PI
Project 3: Ovarian Cancer$240,294
P01 · FY2016 · CA · contact PI
Core A: Biospecimen and High-Dimensional Data Management Core$680,717
P01 · FY2015 · CA · contact PI
Psychological stress, associate biologic mediators, and ovarian cancer risk$412,105
R01 · FY2015 · CA · contact PI
Project 3: Ovarian Cancer$240,125
P01 · FY2015 · CA · contact PI
Biologic Specimen Management Core$403,092
P01 · FY2014 · CA · contact PI
Psychological stress, associate biologic mediators, and ovarian cancer risk$399,742
R01 · FY2014 · CA · contact PI
Ovarian Cancer$161,440
P01 · FY2014 · CA · contact PI
Biologic Specimen Management Core$482,207
P01 · FY2013 · CA · contact PI
Psychological stress, associate biologic mediators, and ovarian cancer risk$389,016
R01 · FY2013 · CA · contact PI
Growth Hormones and Breast Cancer Risk$388,129
R01 · FY2013 · CA · contact PI
Ovarian Cancer$365,128
P01 · FY2013 · CA · contact PI
Biologic Specimen Management Core$473,805
P01 · FY2012 · CA · contact PI
Psychological stress, associate biologic mediators, and ovarian cancer risk$469,872
R01 · FY2012 · CA · contact PI
Growth Hormones and Breast Cancer Risk$421,876
R01 · FY2012 · CA · contact PI
Ovarian Cancer$166,923
P01 · FY2012 · CA · contact PI
Characteristics of tubal ligation and risk of epithelial ovarian cancer$96,177
R03 · FY2012 · CA · contact PI
Biologic Specimen Management Core$474,112
P01 · FY2011 · CA · contact PI
Growth Hormones and Breast Cancer Risk$435,761
R01 · FY2011 · CA · contact PI
Ovarian Cancer$167,104
P01 · FY2011 · CA · contact PI
Characteristics of tubal ligation and risk of epithelial ovarian cancer$101,020
R03 · FY2011 · CA · contact PI
Biologic Specimen Management Core$488,774
P01 · FY2010 · CA · contact PI
Growth Hormones and Breast Cancer Risk$458,063
R01 · FY2010 · CA · contact PI
Ovarian Cancer$172,272
P01 · FY2010 · CA · contact PI
The Role of Prolactin in the Etiology of Postmenopausal Breast Cancer$193,715
R01 · FY2008 · CA · contact PI
The Role of Prolactin in the Etiology of Postmenopausal Breast Cancer$226,000
R01 · FY2007 · CA · contact PI
The Role of Prolactin in the Etiology of Postmenopausal Breast Cancer$232,750
R01 · FY2006 · CA · contact PI